| Project Detail |
Objectives: Knowing your HIV status remains an essential step in accessing treatment and ending the epidemic The general objective of the project in terms of public health is to contribute to the reduction of morbidity and mortality related to HIV / AIDS. This will be achieved by improving access to self-testing among most-at-risk populations, by promoting referral to confirmatory testing, prevention, treatment and care. All this will reduce the number of infections and deaths associated with HIV. Expected Results of the Project The three-and-a-half-year ATLAS project will not only distribute 500,000 self-testing kits for HIV testing in Côte d’Ivoire, Mali and Senegal, but will also lay the groundwork for deployment. large scale of this screening strategy by governments and other partners, with the support of institutional, associative and research partners. 500,000 HIV self-tests to be distributed to change the screening situation among the most-at-risk populations. Objective 1: Participate in the large scale introduction and deployment of HIV self–testing. Objective 2: Diversify distribution channels to reach the target populations of the project, encourage confirmatory testing and treatments. Objective 3: Generate evidence on the results and impact of interventions through scientific studies and promote them. Launch: June 2018 Duration: 3.5 years (2018 – 2021) Countries Impacted: Cote d’Ivoire, Mali, Senegal Funded by UNITAID Partners: Project implemented in consortium with the IRD (Research and Development Institute), in partnership with the Ministries of Health of Senegal, Côte d’Ivoire and Mali and local associations: • CEPIAD, CTA and ENDA Santé in Senegal • AKS, AMPRODE Sahel, ARCAD AIDS, Danayaso, Soutoura and PSI in Mali • Ariel Glaser Foundation, Heartland Alliance International, Ivory Coast Scouts and Ribbon Rouge in Côte d’Ivoire |
